The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis
Song J, Deshpande S, Chang Y, Chiang C, Ahn J, Lessa A, Soni A, Gonzales A, Lee P, Chang Y, Parker T, Kwan J, Chi K, Nanna M. The Association between Glucagon-like Peptide-1 Receptor Agonist and Major Adverse Cardiac and Cerebrovascular Events in Monoclonal Gammopathy of Undetermined Significance: A Propensity-Score Analysis. Blood 2024, 144: 6869. DOI: 10.1182/blood-2024-194867.Peer-Reviewed Original ResearchGLP-1 RA usePropensity Score Matching AnalysisUrinary tract infectionSodium-glucose co-transporter 2 inhibitorsGlucagon-like peptide-1 receptor agonistsPeptide-1 receptor agonistsDipeptidyl peptidase 4 inhibitorsGLP-1 RAsStandardized mean differenceType 2 DMMGUS diagnosisMGUS patientsAssociated with significant reductionsHeart failureRA useGLP-1Decompensated HFMyocardial infarctionMonoclonal gammopathyReceptor agonistsSecondary endpointsIndex dateCerebrovascular eventsDiabetes mellitusRetrospective propensity score-matched analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply